Pulmonary Disease, Chronic Obstructive
"Pulmonary Disease, Chronic Obstructive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Descriptor ID |
D029424
|
| MeSH Number(s) |
C08.381.495.389
|
| Concept/Terms |
Airflow Obstruction, Chronic- Airflow Obstruction, Chronic
- Airflow Obstructions, Chronic
- Chronic Airflow Obstructions
- Chronic Airflow Obstruction
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Disease, Chronic Obstructive".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Disease, Chronic Obstructive".
This graph shows the total number of publications written about "Pulmonary Disease, Chronic Obstructive" by people in this website by year, and whether "Pulmonary Disease, Chronic Obstructive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 5 | 1 | 6 |
| 2004 | 3 | 0 | 3 |
| 2005 | 9 | 4 | 13 |
| 2006 | 8 | 0 | 8 |
| 2007 | 12 | 4 | 16 |
| 2008 | 16 | 1 | 17 |
| 2009 | 8 | 2 | 10 |
| 2010 | 13 | 3 | 16 |
| 2011 | 24 | 1 | 25 |
| 2012 | 15 | 2 | 17 |
| 2013 | 19 | 4 | 23 |
| 2014 | 8 | 3 | 11 |
| 2015 | 19 | 2 | 21 |
| 2016 | 22 | 7 | 29 |
| 2017 | 23 | 3 | 26 |
| 2018 | 36 | 3 | 39 |
| 2019 | 16 | 4 | 20 |
| 2020 | 20 | 2 | 22 |
| 2021 | 16 | 4 | 20 |
| 2022 | 39 | 0 | 39 |
| 2023 | 26 | 0 | 26 |
| 2024 | 18 | 4 | 22 |
| 2025 | 16 | 3 | 19 |
| 2026 | 11 | 1 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pulmonary Disease, Chronic Obstructive" by people in Profiles.
-
Mosaic loss of Y chromosome associates with lung function, emphysema, and epigenetic aging. Am J Respir Crit Care Med. 2026 07 01; 212(7):1483-1494.
-
Correlates of 5-year decline in 6-min walk distance in the COPDGene cohort. Thorax. 2026 Jun 15; 81(7):664-671.
-
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials. Lancet. 2026 May 23; 407(10543):2027-2039.
-
Type 2 Diabetes and the Lung - Cause and Consequence. Curr Diab Rep. 2026 May 07; 26(1).
-
Effect of a self-directed lifestyle-based weight management program among patients with comorbid COPD and sleep apnea: a secondary analysis of the INSIGHT COPD trial. Ann Am Thorac Soc. 2026 03 01; 23(3):419-428.
-
Maternal smoking and CC-16: implications for lung development and COPD across the lifespan. Am J Respir Crit Care Med. 2026 03 01; 212(3):591-604.
-
New approaches to uncover COPD pathobiology and develop therapies. JCI Insight. 2026 Feb 23; 11(4).
-
Proteomic Profiling of Pulmonary Function and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2026 Mar 03; 15(5):e043281.
-
Aberrant cellular communities underlying disease heterogeneity in chronic obstructive pulmonary disease. Nat Genet. 2026 Feb; 58(2):376-391.
-
Multi-trait and multi-ancestry genetic analysis of comorbid lung diseases and traits improves genetic discovery and polygenic risk prediction. Nat Genet. 2026 02; 58(2):289-298.